Company Overview and News

20
Closing The Valuation Gap For Kimco Realty

2018-10-12 seekingalpha
Sears may file bankruptcy any day, but we will just sit back as the high-yielding mall REIT investors head for the hills.
REG COST SKT SHLD TGT SFM KIM

63
Q3 Portfolio Review

2018-10-05 seekingalpha - 1
This is the third quarter review of my retirement income portfolio. It was a very active quarter that included a final pension rollover to my IRA. About half of the rollover funds have been deployed. Some existing positions were trimmed to take profit and to diversify. In recent weeks, I've written articles about the 19 new positions, so this review will be a brief summary.
TXN CNUTF XOM RDSB ENB OPRF RDSA FTS WMT BCE CSCO ABBV DUKH BAMGF SO UPS MAIN TYT KMB CMI ENB MFC RY 0945 BNS JNJ ITW RYDBF 7203 WPC SPG ABBV MSFT QCOM PFE CLX CDUAF BAMKF NNN SOJA TM ADP SKT EPD TD ETN BNS MSCA AAPL BIP RYDAF TD CSCOI BAM BEP CU VTR IBM RDS.B RY RDS.A TNTTF APLE O DUK FDX TOYOF MSCA.CL BLK HP PEP ADPVV FTS PPL MFC

 
This Simple Trick And These 5 High-Yield Blue Chips Could Be Your Best Chance To Retire Rich

2018-09-17 seekingalpha
Merrill Lynch estimates the typical retired couple needs $738,400 to be financially secure over a 30-year retirement.
SKT

 
3 Reasons The Most Undervalued Blue Chip REIT In America Is A Strong Buy

2018-09-16 seekingalpha
REITs have historically been the best way to invest in real estate. They not just deliver market beating returns over time but also generous and rising income.
SKT SPG TCO

20
John And Jane's August Dividend Increases And Income Tracker - Taxable Account

2018-09-13 seekingalpha
August marks the 10th month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $1,665.95.
SOJA GIS XOM IDCC SKT LTC ENB OPRF BPL SEP COP MIC CINF AAPL CAH EMR SO TLP WLK O MSB CMI WLKP ENB ETP HP ORI SPG WPC ADM

31
DGI For The DIY: Q2 2018 Portfolio Update

2018-08-22 seekingalpha
There is uncertainty in the market, but I remain confident that my dividend income will continue its steady march higher.
WFCNP SKT KMI AAPL KMR STAG CVB ABBV MO WFC THO ROST EOG TGT CLDT ABBV DLR SBUX OHI OXY KMRFZ

 
SDY: Showing Improvement

2018-08-20 seekingalpha
The industrials sector has rebounded in the short-term as news of further China and U.S. trade talks have surfaced.
SKT

14
John And Jane's July Dividend Increases And Income Tracker - Taxable Account

2018-08-13 seekingalpha
July marks the ninth month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $640.87.
SOJA GIS XOM SKT LTC OPRF SEP BPL MIC CINF AAPL CAH EMR SO TLP WLK O MSB CMI ETP ORI WPC SPG ADM

 
Does The Tanger Bear Case Hold Water?

2018-08-03 seekingalpha
Leasing spreads appear to be worrisome but diving deeper shows that there might be an explanation.
SKT

14
Tanger Factory Outlet Centers Stock Still Is Risky, Even After Earnings

2018-08-03 investorplace
Tanger Factory Outlet Centers (NYSE:SKT) has become a battleground stock. Some 27% of Tanger stock is sold short at the moment. And of late, the shorts have taken a bit of beating. Heading into its most recent earnings report, Tanger stock had bounced 20% from May lows. And a 2.1% gain in after-hours trading after an earnings beat could add to the pain from the short side.
SKT SPG GGP MAC WPG CBL

 
 
 
Tanger Factory Outlet Centers, Inc. (SKT) CEO Steven Tanger on Q2 2018 Results - Earnings Call Transcript

2018-08-01 seekingalpha
Tanger Factory Outlet Centers, Inc. (NYSE:SKT) Q2 2018 Earnings Conference Call August 1, 2018 10:00 AM ET
DB SKT

 
Tanger Factory Outlet Centers, Inc. 2018 Q2 - Results - Earnings Call Slides

2018-08-01 seekingalpha
The following slide deck was published by Tanger Factory Outlet Centers, Inc. in conjunction with their 2018 Q2 earnings call.
SKT

 
SKT / Tanger Factory Outlet Centers, Inc. 8-K (Current Report)

2018-07-31 sec.gov
Document UNITED STATES
SKT

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to SKT / Tanger Factory Outlet Centers, Inc. on message board site Silicon Investor.

SKTO - SK3 Group, Inc SKTO - SK3 Group, Inc SKTO - SK3 Group, Inc New reconfigurable supercomputer that fits on your desktop New reconfigurable supercomputer that fits on your desktop New reconfigurable supercomputer that fits on your desktop
Media 100 Inc.(MDEA): Desktop Digital Video Media 100 Inc.(MDEA): Desktop Digital Video Media 100 Inc.(MDEA): Desktop Digital Video Web Desktops, Web Applications, Thin Client Web Desktops, Web Applications, Thin Client Web Desktops, Web Applications, Thin Client
SK Technologies otc;bb sktc SK Technologies otc;bb sktc SK Technologies otc;bb sktc the Desktop PROfessional (www.thedp.com) the Desktop PROfessional (www.thedp.com) the Desktop PROfessional (www.thedp.com)
Desktop Video Desktop Video Desktop Video No glue, no cables theft security for notebooks/desktops No glue, no cables theft security for notebooks/desktops No glue, no cables theft security for notebooks/desktops
Gaskins IPO Desktop Gaskins IPO Desktop Gaskins IPO Desktop Desktop Applications, LAN and PC issues Desktop Applications, LAN and PC issues Desktop Applications, LAN and PC issues
CUSIP: 875465106